GenVec (GNVC -33%) gets slammed today after its FQ4 missed hard on the revenue side. Sales were...

|By:, SA News Editor

GenVec (GNVC -33%) gets slammed today after its FQ4 missed hard on the revenue side. Sales were down 56% year over year, impacted by a decline in revenue from its hearing loss and balance disorders, HIV, and foot and mouth disease programs.